It was demonstrated that paeonol reduces paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2 [42] and also exerts an anti-cancer effect on colon cancer cells by suppressing prostaglandin (PGE-2) synthesis and COX-2 expression. Here, TAGLN2 is linked to breast cancer.